Nuformix advances NXP002 programme with £168,750 Placing

Nuformix plc (LON:NFX) raises £168,750 for fibrosis drug development through a new share placing, advancing its NXP002 programme and corporate goals...

Poolbeg Pharma granted extension to PUSU Deadline

HOOKIPA Pharma and Poolbeg Pharma enter talks for a potential acquisition aimed at developing next-generation immunotherapies for critical medical needs...

Strix Group reports FY24 profits ahead of market consensus

Strix Group Plc sees FY24 profits surpass expectations, driven by innovation and strong market presence, with new product launches fueling future growth...

Union Jack Oil plc Positive update on Moccasin 1-13 Well, Oklahoma

Union Jack Oil plc (LON:UJO, OTCQB: UJOGF) reports promising developments at its Moccasin 1-13 well in Oklahoma, highlighting potential oil prospects...

Hardide plc Annual results FY September 2024, well placed for growth, cash generation and value creation

Hardide plc reports FY24 results, showcasing revenue growth, improved profitability, and strategic advancements in aerospace and industrial sectors...

REACT Group plc Final results show increased revenues, growth and profit

REACT Group Plc (LON:REAT) reports strong financial growth for 2024, driven by a 6% revenue boost to £20.7m and enhanced profitability through strategic initiatives...

Nuformix plc Annual Results for the period ended 30 September 2024

Nuformix plc (LON:NFX) targets unmet needs in fibrosis and oncology via drug repurposing, focusing on partnering its NXP002 lead program for IPF and PPF...

hVIVO plc Acquires two Clinical Research Units from CRS for €10.0m

hVIVO expands its clinical footprint by acquiring CRS, a German CRO, adding Phase I & II trial capabilities in Europe, enhancing strategic growth for 2025-2026...

Versarien raises £246,038 via Placing

Versarien plc (LON:VRS) raises £246,038 through a placement of 745 million new shares, enhancing corporate funding and shareholder transparency...

Nuformix submits NXP002 Orphan Drug Designation Application to EMA

Nuformix plc (LON:NFX) advances NXP002 for Idiopathic Pulmonary Fibrosis, applying for Orphan Drug Designation with European Medicines Agency...

United Utilities Group Plc forthcoming key corporate dates

Stay informed with United Utilities Group's financial calendar for 2025, featuring updates on dividends, results, and key shareholder events...

Rentokil Initial Plc FY 2024 results in line with expectations

Rentokil Initial reports strong Q4 2024 performance with 3.0% organic revenue growth. Brad Paulsen to step down, Alain Moffroid named interim CEO...

GSK plc Depemokimab applications accepted for review in China and Japan

GSK's depemokimab, an ultra-long-acting biologic, is up for regulatory review in China and Japan for asthma and CRSwNP, based on positive trial results...

GSK Plc Shingrix new prefilled syringe presentation accepted for review by EMA

GSK's innovative prefilled Shingrix syringe gains EMA review, aiming to simplify shingles prevention for healthcare professionals across Europe...

Severn Trent Plc on track to perform in line with guidance

Severn Trent Plc (LON:SVT) reports a strong trading update, endorses PR24 Final Determination, and outlines its AMP8 dividend growth policy...

Associated British Foods Plc downgrades Primark sales growth for 2025

Associated British Foods plc (LON:ABF) reveals mixed outcomes in its early 2025 trading update, with varied performance across business segments...

Apax Global Alpha appoints Investec Bank as joint corporate broker

Apax Global Alpha Limited appoints Investec Bank as joint corporate broker with Jefferies, enhancing strategic investment services from February 2025...

European Opportunities Trust Plc portfolio performance falls behind Benchmark

European Opportunities Trust Plc (LON:EOT) reports a 6-month NAV total return of -8.4% to 30 Nov 2024, compared to -3.3% for MSCI Europe Index...

Victrex Plc reports strong Q2, trading conditions remain mixed

Victrex plc leads in sustainable polymer solutions, with strong Q1 FY 2025 progress despite mixed conditions. Revenue up 9%, volume up 20% year-on-year...

JTC Plc achieves record performance in new business wins

JTC Plc (LON:JTC) reports a successful start to its Cosmos era, doubling growth targets, acquisitions, and notable US market expansion in 2024...

Molten Ventures Plc hosting Investor Day on 12 February

Join Molten Ventures' Investor Day on Feb 12 to explore trends in European tech with insights from industry leaders and CEO Ben Wilkinson...

Grainger Plc delivers strong portfolio growth, robust rental performance

Grainger plc, the UK's top private rental homes provider, reports a 15% surge in net rental income, driven by a robust Build to Rent market...

AIM All Share Index

Trending Articles

Search

Search

Currency